Latest Drug Shortages
Medications may be commercially unavailable for a variety of reasons, the most common being:
- back-ordered due to a manufacturing problem
- discontinued due to decreased usage or declining manufacturer profits, which may be related to the introduction of a newer drug
(Note: Drugs are also withdrawn from the market due to health risks, and we do not compound medications that were discontinued due to safety concerns.)
Sometimes only certain doses and dosage forms of a particular drug, or specific combinations are discontinued.
Our professional pharmacists can help by obtaining the Active Pharmaceutical Ingredient (API) and compounding the needed drug in the most appropriate dose, dosage form, and flavor for each patient. We can also compound medications that are free of problem-causing additives such as sugar, alcohol, preservatives, dyes, and gluten. We utilize the finest FDA approved chemicals, follow current USP guidelines, and are licensed and regulated by our State Board of Pharmacy.
Shortages of Oral and Topical Medications:
Liotrix (Thyrolar) Tablets
Sumatriptan Nasal Spray
Shortages of Veterinary Medications
Shortages of Injections, Ophthalmic Preparations, and other Sterile Medications:
Ammonium Chloride Injection
Atropine Sulfate Injection
Caffeine Anhydrous (125mg/mL); Sodium Benzoate (125mg/mL) Injection
Calcium Chloride Injection
Calcium Gluconate Injection
Dexamethasone Sodium Phosphate Injection
Fentanyl Citrate Injection
Leucovorin Calcium Injection
Phentolamine Mesylate Injection
Potassium Chloride Injection
Sodium Bicarbonate Injection
Sodium Chloride Injection
Actifed®, Actifed-C® Liquid
Chlorpromazine Oral Solution and Suppositories
Dexamethasone – various
Mycelex-G® Vaginal Tablets
Nystatin Vaginal Tablets
In addition to the above, there are countless products and “remedies” that are no longer commercially available, but that physicians and patients report are very useful in treating a specific problem. Ask our compounding pharmacist for more information.
© Storey Marketing. All rights reserved.